33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-200.00%
Cash & equivalents declining -200.00% while PATH's grows 402.19%. Howard Marks would question why our liquidity is shrinking while competitor builds cash.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Receivables growth above 1.5x PATH's -14.04%. Michael Burry would check for potential credit bubble or inflated top-line.
-100.00%
Inventory growth below half of PATH's 2712399900.00%. David Dodd would check if that's due to efficiency or supply constraints.
-100.00%
Above 1.5x PATH's -41.17%. Michael Burry might investigate for potential short-term asset misclassification or risk.
-18.59%
Below half of PATH's 188.65%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
-100.00%
≥ 1.5x PATH's -1.38%. David Dodd sees more aggressive capex. Confirm it's not overspending.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Less than half of PATH's 100.40%. David Dodd sees relatively fewer intangible expansions. Possibly more tangible-driven.
-100.00%
Less than half of PATH's 106.28%. David Dodd sees fewer intangible expansions vs. competitor. Possibly safer balance sheet.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-300.32%
Above 1.5x PATH's -23.26%. Michael Burry warns of potential hidden liabilities or intangible bloat.
-201.12%
Below half of PATH's 41.38%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Below half of PATH's 166.21%. Michael Burry sees a potential red flag for stagnation or capital shortage.
-100.00%
Above 1.5x PATH's -15.56%. Michael Burry questions if payables are being stretched to avoid short-term borrowing.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Below half of PATH's 5.22%. Michael Burry suspects a big gap in pre-sales traction.
-100.00%
1.1-1.25x PATH's -80.41%. Bill Ackman wonders if the firm is incurring more one-time charges than competitor.
-100.00%
Above 1.5x PATH's -10.01%. Michael Burry sees a red flag for liquidity risk vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
≥ 1.5x PATH's -9.95%. David Dodd sees stronger long-horizon revenue vs. competitor.
-100.00%
Similar yoy changes to PATH's -100.00%. Walter Schloss sees parallel tax deferral patterns.
-100.00%
1.1-1.25x PATH's -85.13%. Bill Ackman questions if the firm is incurring extra obligations vs. competitor.
-100.00%
Similar yoy to PATH's -93.99%. Walter Schloss sees parallel expansions in long-term liabilities.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
1.25-1.5x PATH's -75.63%. Martin Whitman is wary of bigger liability expansions.
-100.00%
Less than half of PATH's 150.00%. David Dodd sees fewer share issuances vs. competitor.
100.00%
Below half PATH's -24.70%. Michael Burry suspects major net losses or high dividends vs. competitor.
-468658475051148992.00%
Less than half of PATH's 33.76%. David Dodd sees fewer intangible or market-driven swings than competitor.
No Data
No Data available this quarter, please select a different quarter.
178.13%
0.5-0.75x PATH's 336.35%. Martin Whitman is wary of lagging equity growth vs. competitor.
-53.05%
Below half PATH's 166.21%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Above 1.5x PATH's -35.41%. Michael Burry sees a major jump. Investigate leverage rationale.
276.46%
Less than half of PATH's -428.21%. David Dodd sees better deleveraging or stronger cash buildup than competitor.
